SubQ vs IM injections for peptides: what the evidence shows

What did @kylraggio.ifbbpro actually say?

The creator walked viewers through subcutaneous injection technique, focusing on abdominal sites. His main recommendations: divide the abdomen into six quadrants roughly corresponding to the rectus abdominis sections, rotate injection sites to prevent scar tissue, and "grab a fold of skin" to avoid injecting into the abdominal wall itself. He also specified insulin needles in the 29-31 gauge range, approximately half an inch in length. He framed subQ as a viable route for both peptides and hormone replacement therapy, calling it "super simple, super easy and super pain free."

Worth noting: the caption for this video suggests he believes subQ is better suited to water-based peptides than to oil-based TRT compounds, though he doesn't make that distinction clearly in the spoken transcript. That gap matters, as we'll get into below.

Does the science back this up?

Mostly, yes, though some claims are more solid than others. The subQ rotation principle is well-established, and the needle gauge recommendations are clinically appropriate. Where things get murkier is the claim that subQ is a "perfectly viable solution" for hormone replacement therapy broadly.

On rotation: lipohypertrophy from repeated injections at the same site is a documented phenomenon, most thoroughly studied in insulin-dependent diabetics. Famously, Blanco et al. (2013, Diabetes Research and Clinical Practice) found that 49.1% of insulin users injected into areas of lipohypertrophy, leading to erratic absorption. The principle transfers logically to peptide and hormone administration, even if direct studies on TRT subQ rotation are thinner.

On subQ for TRT: a randomized crossover study by Shrimanker et al. (2021, Journal of the Endocrine Society) found that subQ testosterone cypionate produced stable serum levels with lower peak-to-trough variability than intramuscular administration. So subQ TRT is legitimate medicine. However, oil-based testosterone formulations at higher volumes can cause localized inflammation and poor absorption when given subQ, a nuance the creator glosses over entirely.

On needle specs: 29-31 gauge, half-inch needles are standard for subQ delivery. The FDA's guidance on injection technique and published nursing protocols both confirm this range is appropriate for subcutaneous tissue depth in average adults.

What did they get wrong (or right)?

Credit where it's due: the technique he demonstrates, pinching a skin fold, injecting at a shallow angle, rotating sites, is textbook correct for subQ administration. The quadrant system is a practical mnemonic borrowed loosely from diabetic injection education, and it works.

What he got wrong, or at least incomplete: the blanket statement that subQ injections are a "perfectly viable solution" for hormone replacement therapy without distinguishing compound type, volume, or formulation. Oil-based injectables at volumes above roughly 0.5-1 mL subQ are associated with increased injection site reactions and inconsistent absorption. Testosterone cypionate in sesame or cottonseed oil behaves very differently subQ than an aqueous peptide solution does. Rahnema et al. (2014, Fertility and Sterility) and clinical endocrinology guidelines from the Endocrine Society both note that subQ TRT requires lower volumes and appropriate formulations. The creator doesn't acknowledge this at all.

He also describes the procedure as "super pain free," which is generally true for fine-gauge needles but can be misleading. Peptides reconstituted with bacteriostatic water at certain pH levels, or oil-based compounds given subQ, can cause notable stinging or nodule formation. Telling beginners to expect zero discomfort sets them up to think something is wrong when they feel normal injection-site sensation.

What should you actually know?

SubQ injection technique, done correctly, is a legitimate and widely used administration route in clinical medicine. The basics this creator covers are accurate enough for someone already working under medical supervision. The problems show up in what he leaves out.

First, subQ is not universally equivalent to intramuscular for all compounds. Volume matters. Formulation matters. A 29-gauge insulin syringe loaded with 0.1 mL of reconstituted BPC-157 is a completely different clinical scenario than trying to push 1 mL of testosterone cypionate subQ. Anyone using this video as a guide for the latter could run into real problems.

Second, self-injection guidance from social media, even technically accurate guidance, exists in a regulatory gray zone. Compounded peptides like BPC-157, TB-500, and CJC-1295 are not FDA-approved drugs. Their sterility, concentration, and purity depend entirely on the compounding pharmacy producing them. The technique being correct doesn't solve the upstream question of whether the compound itself is what it claims to be.

Third, if you are on a medically supervised program, your prescribing provider should be the one walking you through injection technique, not an IFBB pro on TikTok. This video is educational in the loosest sense, but it is not a substitute for individualized medical instruction.